-
ASCO 2024 | Dr. Chang Liu: Dual Immunotherapy Offers New Options for PD-1 Resistant Gastric Cancer Patients
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting has successfully concluded, showcasing groundbreaking oncology research. Dr. Chang Liu from Professor Lin Shen’s team at Peking University Cancer Hospital presented their study on the efficacy and safety of CCR8 monoclonal antibody LM-108 combined with PD-1 antibody in gastric cancer patients. Professor Shen’s presentation at…
-
Dr. Ye Wei: Comprehensive Treatment and Guideline-Driven Care in Colorectal Cancer丨The CACA Guideline Journey Across China
Led by the Chinese Anti-Cancer Association (CACA), top oncology experts across various fields collaborated over a year to develop China’s first integrated oncology guideline, the CACA Integrated Cancer Diagnosis and Treatment Guideline, which was published in 2022. As part of a national educational tour on the guideline, Dr. Ye Wei from Huadong Hospital Affiliated to…
-
9th Academic Symposium of the CCIHPBA丨Dr. Tianqiang Song: Advancements in Perioperative Treatments for Liver Cancer and the Tianjin Experience
The 9th Academic Symposium of the Chinese Branch of the International Hepato-Pancreato-Biliary Association (IHPBA) was held in Wuhan from October 25-27, 2024, drawing renowned experts from over 20 countries, including the United States, Germany, France, Russia, and Australia. With more than 50 prominent international scholars, 21 academicians, and over 700 experts in liver, gallbladder, and…
-
Case Study丨Dr. Jia Shang: Diagnosis and Treatment of Invasive Fungal Infection in Severe Liver Disease Patients
Case Information The patient is a 61-year-old female who, five years ago, presented with “jaundice” at a local hospital, where she was diagnosed with cirrhosis. She subsequently came to our…
-
IDWeek 2024 Highlights: Advancements in RSV Prevention for Children with Vaccines and Monoclonal Antibodies
1. Clesrovimab for RSV Prevention in High-Risk Infants and Children RSV infects approximately 12.9 million infants globally each year, causing significant respiratory infections and hospitalizations, particularly in high-risk groups like…
-
2024 CACA Integrated Lung Cancer Conference | Prof. Li Zhang: Striving for Breakthroughs – The Advantages and Challenges of ADC Therapy for NSCLC
The 2024 CACA Integrated Lung Cancer Conference, organized by the Chinese Anti-Cancer Association and the CACA Lung Cancer Integration Committee, was held in Zhuhai from October 25 to 26. Under the theme “Gathering Strength and Leading the Future,” the conference brought together top experts in lung cancer to discuss key challenges and advancements. Oncology Frontier…
-
SIBCS 2024 | Hot Topics: China’s Breast Cancer Clinical Practice Controversy & Consensus Voting and a Preview of the 2025 CBCS Guidelines Update
From October 17 to 19, 2024, the 18th National Breast Cancer Conference and the 19th Shanghai International Breast Cancer Symposium (SIBCS 2024) took place in Shanghai. During this period, the fourth Controversy & Consensus Consortium (3C) Summit, focusing on clinical practice in Chinese breast cancer, was successfully held. Leading breast cancer experts and patient representatives…
-
The 9th Congress of the CCIHPBA l Dr.Tiangiang Song: Advancements Perioperative Treatments for Liver Cancer and the Tianiin Experience
The 9th Congress of the Chinese Chapter of the International Hepato-Pancreato-Biliary Association (CCIHPBA) and The Seminar on the Academic Thoughts of Prof. Oiu Fazu and his 110 Birth Anniversary and Sino -Geman Medical Educaton Fomum, along with A Commemorative Ceremony in honor of the late Prof. Wan Yee Joseph LAU, were held in Wuhan from…
Connecting Medical Expertise through Media